Year 5, N°17, September, 2002
Special Issue: World Congress of Nuclear Medicine

Poster Abstracts

Article Nº AJ17-26

10. ONCOLOGY DIAGNOSIS
M. Baczy
10.01

DYNAMIC LYMPHOSCINTIGRAPHY IN DIAGNOSIS AND MANAGEMENT OF POSTMASTECTOMY LYMPHOEDEMA

G.P. Bandopadhyaya

10.02

BRAIN SPECT: TC-99M CITRIC ACID AS KREB CYCLE PRECURSOR FOR THE ASSESSMENT OF GILOBLASTOMA MULTIFORME INVOLVING CORPUS COLLOSUM

T.Y. Chao

10.03

CORRELATIONS BETWEEN ACTIVITY OF TARTRATE-RESISTANT ACID PHOSPHATASE- 5B AND WHOLE BODY BONE SCAN IN PATIENTS OF BREAST CANCER WITH BONY METASTASES

I. Cho

10.04

IS SUBAREOLAR INJECTION HELPFUL TO DETECT SENTINEL NODES (SNS) IN BREAST CANCER (BRCA)?

L. Engelin

10.05

SPECT/CT AND COINCIDENCE DETECTION-PET/CT FOR 3D LOCALIZATION OF METASTASES AND SENTINEL NODES IN PATIENTS WITH A RAPID LYMPHATIC DRAINING - A CASE REPORT

M. Farsad

10.06
ROLE OF METHODS FOR SENTINEL NODES DETECTION IN PATIENTS WITH CUTANEOUS MELANOMA

C. Gamez

10.07

FDG-PET IDENTIFICATION OF INTRAPERITONEAL METASTASES

M. Georgiev-Predic

10.08

DIAGNOSIS THE METASTATIC SENTINEL NODE WITH TC-99M-MIBI

S. Gerali

10.09

TC99M-MIBI SCINTIGRAPHY IN THE FOLLOW-UP OF PATIENTS WITH METASTATIC DIFFERENTIATED THYROID CARCINOMA

I. Hervás

10.10

HODGKIN'S DISEASE. PROGNOSTIC VALUE OF 67-GALLIUM WHOLE BODY SCAN

I. Hervás

10.11

111IN-OCTREOTIDE AND 99MTC-MDP SCINTIGRAPHY IN THE DETECTION OF BONE LESIONS IN LANGERHANS CELL HISTIOCYTOSIS

T. Higashi

10.12

CLINICAL USEFULNESS OF DUAL-PHASE FDG-PET IN PANTIENTS WITH PANCREATIC CANCERS.

LJ. Jaukovic

10.13

99M-TC TETROFOSMIN SCINTIGRAPHY VS MAMMOGRAPHY IN BREAST CANCER DETECTION

K.W. Kang

10.14

CORPUS LUTEUM MIMICS A PELVIC LESION ON FDG PET IN WOMEN OF CHILDBEARING AGE

S.I. Koukouraki

10.15

COMPARISON OF 99MTC SESTAMIBI SCINTIMAMMOGRAPHY WITH 99MTC CEA SCAN IN THE DIAGNOSIS OF BREAST CANCER

J.J. Lemberger

10.16

POSTOPERATIVE SERUM CEA LEVEL AS PREDICTIVE FACTOR FOR SURVIVAL IN PATIENTS WITH COLORECTAL CANCER

S.M. Lim

10.17

METABOLIC EVALUATION OF BRAIN TUMORS BY POSITRON EMISSION TOMOGRAPHY USING F-18 LABELED FLUOROETHYLTYROSINE COMPARED TO F-18 FDG

E.N.P. Lima

10.18

WHOLE BODY 67-GALLIUM SCINTIGRAPHY IN NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS: A RETROSPECTIVE STUDY 109 PATIENTS AND 126 WHOLE BODY SCANS 67-GA

I. Makaiova

10.19

EXPERIENCES WITH PET/18FDG IN GYNECOLOGICAL CARCINOMAS

E. F. Martins

10.20
NUCLEAR DACRYOSCINTOGRAPHY IN ONCOLOGIC PATIENTS POSTOPERATIVE THE TUMOUR OF THE FACE

S. Maza

10.21

VALUE OF THE SUBAREOLAR APPLICATION OF TC-99M NANOCOLLOID IN THE SENTINEL NODE DETECTION FOR NOT PRECISELY LOCALLY DEFINED MULTIFOCAL/CENTRIC BREAST CARCINOMAS AT EARLY STAGES

M. Myslivecek

10.22

EVALUATION OF MULTIPLE MYELOMA WITH TECHNETIUM-99M-MIBI SCINTIGRAPHY

S. Neubauer

10.23

TC99M - DEXTRAN SENTINEL NODE DETECTION: IMPROVEMENT OF CLINICAL DECISION MAKING IN MALIGNANT SKIN LESIONS

R. Nishii

10.24

SYNTHESIS AND BIODISTRIBUTION STUDY OF 3-IODO-4-HYDROXYPHENYL-CYSTEAMINE FOR DETECTION OF MALIGNANT MELANOMA BASED ON SPECIFIC ENZYME OF MELANIN FORMATION

P.V.P. Pedras

10.25

RESEARCH OF WHOLE BODY WITH I-131 USING RECOMBINANT TSH ALPHA-THYROTROFIN OUR EXPERIMENT

Y.P. Peña

10.26

VALUE OF THE SCINTIGAMMAGRAPHY WITH 99MTC-GLUCOHEPTONATE IN THE DIAGNOSIS OF THE BREAST CANCER.

Z. Rajkovaca

10.27

COMPARISON OF CA15-3 AND CEA IN BREAST CANCER

R. Sancho

25.28

CHANGES IN TUMOR MICROVASCULAR SPACE AND INTERSTITIAL FLUID VOLUME AS A FUNCTION OF TUMOR SIZE.

S. Sergieva

10.29

THE ROLE OF RADIONUCLIDE BONE SCANNING IN FOLLOW-UP OF ASYMPTOMATIC PATIENTS WITH EARLY BREAST CANCER (STAGE TIA-C)AND BONE MARROW MICRO METASTASES

M.P. Sierralta

10.30

PRELIMINARY EVALUATION OF INTRAOPERATIVE GAMMA PROBE DETECTION OF THE SENTINEL NODE

H.S. Soh
10.31

BREAST SCINTIGRAPHY USING TC-99M MIBI IN PATIENTS WITH MALIGNANT BREAST MASS: THE CORRELATION BETWEEN SCINTIGRAPHY AND HISTOPATHOLOGY

G. Villa

10.32

PREDICTION OF DISEASE STATUS BY RECOMBINANT HUMAN TSH-STIMULATED SERUM TG IN THE POSTSURGICAL FOLLOW-UP OF DIFFERENTIATED THYROID CARCINOMA. TWO-YEAR EXPERIENCE

B. G. Viterbo

10.33

EVALUATION OF PATIENTS WITH METASTATIC BONE LESIONS FROM BREAST CARCINOMA USING WHOLE BODY SCINTIGRAPHY WITH PENTAVALENT TECHNETIUM-99M DIMERCAPTOSUCCINIC ACID: PRELIMINARY RESULTS

J. Vizda

10.34

IMMUNOSCINTIGRAPHY AND INTRAOPERATIVE RADIOIMMUNODETECTION IN COLORECTAL CANCER: COMPARISON OF 111IN-SATUMOMAB AND 99MTC-ARCITUMOMAB

K. Vonorta

10.35

THE ROLE OF SCINTIMAMMOGRAPHY WITH 99M-TC-TETROFOSMIN IN BREAST CANCER DETECTION

T.C. Yen

10.36

PRIMARY (RECURRENT) AND METASTATIC LESIONS DETECTION IN CERVICAL CANCER: A COMPARISON OF POSITRON EMISSION TOMOGRAPHY, CT AND/OR MRI IMAGE AND PATHOLOGICAL STUDY

M.N. Younis

10.37

PREDICTION OF RESPONSE TO CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER PATIENTS USING TC-99M MIBI SCINTIMAMMOGRAPHY

Cardiovascular |Cost Benefits|Endocrinology |Gastroenterology |Hematology |Infection| Musculoskeletal |Nephro-Urology |Neuro-Psychiatric Disorders |Oncology Diagnosis |Oncology Therapy |Pediatrics|Physics |Pulmonary |Radiopharmacy |Technology

 

 

Sitio desarrollado por SISIB - Universidad de Chile